GLP-1/GIP/Glucagon Agonist
Synthetic triple receptor agonist peptide. Studied in vitro for GLP-1, GIP, and glucagon receptor binding activity and downstream cAMP signaling in cell-culture models.
$149.99
For laboratory research use only. Not for human consumption. Not approved by the FDA for human or veterinary use.
AGR-GLP3 is a synthetic peptide characterized as a triple agonist of the GIP, GLP-1, and glucagon receptors. In laboratory settings it is used to study receptor-binding affinity, cAMP signaling, and receptor-internalization kinetics in transfected cell lines. Identity and purity are confirmed by HPLC and mass spectrometry on every lot.
Studied research pathways: GIP receptor binding, GLP-1 receptor signaling, Glucagon receptor activity